TransGenRx, a Baton Rouge biotech firm that produces specialized proteins, has won a contract worth up to $30 million to make human-growth hormone for Laboratorio Pablo Cassara SRL, an Argentine drug-maker.
The contract calls for TransGenRx Inc. to make 66 pounds of human-growth hormone in the next 12 to 18 months, company President William Fioretti said Wednesday.
TransGenRx will be paid roughly $1 million for every kilogram, or 2.2 pounds, of the hormone. It’s used to treat abnormally short children and adults who don’t produce enough of the hormone.
No comments:
Post a Comment